IL2 and neuroblastoma: By contrast, only 30% of those cells pre-conditioned with IL-15 or IL-15 plus IL-2 underwent apoptosis (30.5 ± 4.97% in HC and 24 ± 5.64% in NB patients) (Fig. 3D, E).